$MODDJun 26, 2026, 11:58 AMAI processed
Modular Medical (MODD) begins shipping Pivot tubeless insulin patch pumps to physician offices
AI Summary
Modular Medical (MODD) said it has started shipping Pivot tubeless insulin patch starter kits to endocrinology offices for staff training, with trained practices set to present pumps to potential patients in the coming days and weeks. The company plans a phased commercial rollout targeting select high-volume endocrinology practices and broader metropolitan expansion by late 2026, aiming at adults on multiple daily injections (estimated 70% of insulin-dependent adults).
Positives
- Starter kits for the Pivot tubeless patch pump are now shipping to physician offices for training
- Trained practices will begin presenting the device to potential patients in days-to-weeks
- Company plans phased commercial rollout targeting high-volume endocrinology practices with broader expansion by late 2026
Negatives
- Current shipments are for office training, not widespread patient use yet
- Adoption and conversion of injection patients to the Pivot pump remain unproven
- Company flags manufacturing, commercialization, and market acceptance risks in forward-looking statements